EO, Wan Kyu

Position : MD, Ph.D., Chief, Section of Hematology/Medical Oncology

Specialty : 

  • Hematologic cancer, Lymphoma, Stomach cancer, colon cancer

Education :

  • Mar. 1980~Feb. 1986: School of Medicine, Kyung Hee University, Seoul, South Korea(M.D.)
  • Mar. 1988~Aug. 1990: Graduate School of Kyung Hee University, Seoul, South Korea(Master ,Endocrinology)
  • Mar. 1991~Feb. 1995: Graduate School of Kyung Hee University, Seoul, South Korea(Ph.D.,
  • Hematooncology)
  • Mar. 2008~Aug. 2014: Graduate School of Sangji University, Wonju, Gangwon-do, South Korea
  • (Ph.D.,Preventive medicine)

Experience :

  • Mar. 1987~Feb. 1988: Internship in Medicine, Kyung Hee University Hospital, Seoul, South Korea
  • Mar. 1988~Feb. 1991: Residency in Internal Medicine, Kyung Hee University Hospital, Seoul, South Korea
  • Mar. 1992~Feb. 1996: Instructor, Division of Hemato-oncology, Dept. of Internal Medicine, Kosin University Hospital, Pusan, South Korea
  • Mar. 1996~Aug. 2000: Assistant Professor, Division of Hemato-oncology, Dept. of Internal Medicine, Kosin University Hospital, Pusan, South Korea
  • Mar. 1999~Feb. 2000: Associate, BMT Unit, Yale New Haven Hospital, CT, USA
  • Jan. 2000~ Feb. 2000: Clinical Observer, Allogeneic BMT, Memorial Sloan-Kettering Cancer Center, NY, USA
  • Sep. 2000~Jan. 2006: Associate Professor, Division of Hemato-oncology, Dept. of Internal Medicine, Kosin University Hospital, Pusan, South Korea
  • Feb. 2006~Present: Professor, Division of Hemato-oncology, Dept. of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea
  • Board Certification in Internal Medicine, South Korea (1990)
  • Board Certification in Hematology/Medical Oncology, South Korea (1996)
  • Board Certification in Complement/Alternative Medicine, South Korea (2009)

Research papers/ Book chapters: 

  • Preoperative lymphocyte-monocyte ratio is a predictor of suboptimal cytoreduction in stage III-IV epithelial ovarian cancer (JOURNAL OF CANCER. 2016;7(13):1772-1779)
  • The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer (JOURNAL OF CANCER. 2016;7(5):538-545)
  • The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian Cancer (JOURNAL OF CANCER. 2016;7(3):289-296)
  • Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma (ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE. 2016;25(3):513-521)
  • Detection of angiogenic factors in midtrimester amniotic fluid and the prediction of preterm birth (Taiwanese Journal of Obstetrics and Gynecology. 2016;55(4):539-544)
  • Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer (JOURNAL OF CANCER. 2016;7(8):957-964)
  • Bone Density in Patients with Cervical Cancer or Endometrial Cancer in comparison with Healthy Control; According to the stages (JOURNAL OF CANCER. 2015;6(8):686-693)
  • The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer (NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL. 2015;67(8):1260-1267)
  • Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer (WORLD JOURNAL OF GASTROENTEROLOGY. 2015;21(9):2668-2676)
  • Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients (WORLD JOURNAL OF GASTROENTEROLOGY. 2015;21(43):12410-12420)
  • DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers (BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2014;447(2):315-322)
  • Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series (EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2013;0(0):0-0)
  • etc.